Product Code: GVR-1-68038-431-4
Hyaluronic Acid Raw Material Market Growth & Trends:
The global hyaluronic acid raw material market size is expected to reach USD 10.8 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 6.5% from 2023 to 2030. The increasing use of hyaluronic acid in various medical applications, such as osteoarthritis, wound healing, postoperative adhesion, tympanic membrane repair, tumor diagnosis, fracture healing, and soft tissue repair is expected to fuel the market growth over the forecast period.
The orthopedics segment dominated the overall market in 2015 with the highest revenue generation. The increasing geriatric population base, rising incidence of osteoarthritis, and growing adoption of viscosupplements in the treatments contribute to the large market share of this segment. Furthermore, the drug delivery segment is projected to be the fastest growing over the forecast period with a significantly higher CAGR. The increasing R&D activities focusing on targeted drug delivery systems and growing usage of hyaluronic acid in anti-cancer drug delivery is expected to contribute to the market growth.
The increasing women population of age 35 to 65 years across the globe engenders a greater demand for anti-aging cosmetic and aesthetic treatments. Owing to the distinctive viscoelastic and moisturizing properties coupled with lower toxicity levels offered by hyaluronic acid-based products, the demand for this polymer in dermal fillers as well as in the treatment of vesicoureteral reflux is expected to experience growth. Thus, it is anticipated that the need for such products will serve as a high impact driver for the hyaluronic acid products over the forecast period. Based on the statistics of the International Society of Aesthetic Plastic Surgery in 2014, there were approximately 20 million cosmetic procedures performed globally, of which nearly 13.5% of the procedures were HA-based non-surgical procedures.
Some of the top countries recording a majority of the aesthetic treatments in 2014 were the U.S., Brazil, Japan, South Korea, Mexico, Germany, France, and Colombia. Medical tourism for cosmetic surgery in the U.S. plays a very important role in aiding the uptake of HA-based products and procedures, which is expected to drive the market in the coming few years.
Hyaluronic Acid Raw Material Market Report Highlights:
- The orthopedics segment dominated the market in 2022 with the largest revenue share of 39.7% owing to the growing adoption of technologically advanced drugs coupled with the wide usage of hyaluronic acid in the treatment procedures of osteoarthritis.
- The introduction of FDA-approved hyaluronic acid-based viscosupplements such as ORTHOVISC and MONOVISC is expected to boost usage over the next 8 years
- Some of the key market players are Salix Pharmaceuticals; ALLERGAN; Lifecore Biomedical, LLC; Anika Therapeutics, Inc.; Smith & Nephew; Maruha Nichiro Corporation; Ferring B.V.; SEIKAGAKU CORPORATION; F. Hoffmann-La Roche Ltd., Zimmer Biomet; and others
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Application
- 1.1.2. Source
- 1.1.3. Grade
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.2.2. Source outlook
- 2.2.3. Grade outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Hyaluronic Acid Raw Material Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Hyaluronic Acid Raw Material Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Hyaluronic Acid Raw Material: Application Estimates & Trend Analysis
- 4.1. Hyaluronic Acid Raw Material Market: Key Takeaways
- 4.2. Hyaluronic Acid Raw Material Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Ophthalmology
- 4.3.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.2. Cataract surgery
- 4.3.2.1. Cataract surgery market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.3. Aqueous eye drop
- 4.3.3.1. Aqueous eye drop market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.4. Contact lens
- 4.3.4.1. Contact lens market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Orthopedics
- 4.4.1. Orthopedics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Viscosupplements
- 4.4.2.1. Viscosupplements market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Bone regeneration
- 4.4.3.1. Bone regeneration market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Dermatology
- 4.5.1. Dermatology market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.2. Intradermal
- 4.5.2.1. Intradermal market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.3. Dermal filler
- 4.5.3.1. Dermal filler market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.4. Wound healing
- 4.5.4.1. Wound healing market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Drug Delivery
- 4.6.1. Drug delivery market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.7. Medical Device Coating
- 4.7.1. Medical device coating market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.8. Surgical Adhesion Prevention
- 4.8.1. Surgical adhesion prevention market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.9. Biomaterials and Implants
- 4.9.1. Biomaterials and implants market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.10. Cell and Tissue Preservation
- 4.10.1. Cell and tissue preservation market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Hyaluronic Acid Raw Material Market: Source Estimates & Trend Analysis
- 5.1. Hyaluronic Acid Raw Material Market: Key Takeaways
- 5.2. Hyaluronic Acid Raw Material Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Non-Animal
- 5.3.1. Non-Animal market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Animal
- 5.4.1. Animal market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Hyaluronic Acid Raw Material Market: Grade Estimates & Trend Analysis
- 6.1. Hyaluronic Acid Raw Material Market: Key Takeaways
- 6.2. Hyaluronic Acid Raw Material Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Pharmaceutical
- 6.3.1. Pharmaceutical market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4. Cosmetic
- 6.4.1. Cosmetic market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Orthopedic
- 6.5.1. Orthopedic market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Hyaluronic Acid Raw Material Market: Regional Estimates & Trend Analysis
- 7.1. Regional Outlook
- 7.2. Hyaluronic Acid Raw Material Market by Region: Key Takeaway
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
- 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
- 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
- 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
- 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
- 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Sweden
- 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Norway
- 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
- 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
- 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
- 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
- 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
- 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
- 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
- 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Market Participant Categorization
- 8.2.1. AbbVie Inc.
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Salix Pharmaceuticals
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Lifecore Biomedical, Inc.
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Sanofi
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Anika Therapeutics, Inc.
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Zimmer Biomet
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Smith+Nephew
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. LG Chem
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Maruha Nichiro Corporation
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Ferring B.V.
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.11. SEIKAGAKU CORPORATION
- 8.2.11.1. Company overview
- 8.2.11.2. Financial performance
- 8.2.11.3. Product benchmarking
- 8.2.11.4. Strategic initiatives
- 8.2.12. F. Hoffmann-La Roche Ltd.
- 8.2.12.1. Company overview
- 8.2.12.2. Financial performance
- 8.2.12.3. Product benchmarking
- 8.2.12.4. Strategic initiatives